Developing a vaccine using Vero cells for respiratory syncytial virus (RSV)
Task V08: Process Development for Scale-up of Vero Cells on Micro-Carriers for Manufacturing of a Live-Attenuated RSV Vaccine
This study is working on making a safe and effective vaccine to protect babies and young kids from respiratory syncytial virus (RSV), which often causes breathing problems, by improving how the vaccine is produced.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project ID | NIH-10329660 on NIH RePORTER |
What this research studies
This research focuses on the development and manufacturing processes for a live-attenuated vaccine against respiratory syncytial virus (RSV) using Vero cells grown on micro-carriers. The project involves optimizing the production methods to ensure compliance with good manufacturing practices (cGMP) for clinical trials. Patients may benefit from this research as it aims to create a safe and effective vaccine to protect against RSV, a common cause of respiratory infections in infants and young children.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include infants and young children who are at high risk for severe RSV infections.
Not a fit: Patients who are not at risk for RSV infections or those who have already been vaccinated against RSV may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new vaccine that significantly reduces the incidence of RSV infections in vulnerable populations.
How similar studies have performed: Other research has shown success in developing vaccines using similar methodologies, indicating a promising approach for this project.
Where this research is happening
Dessau-Rosslau, Germany
- Idt Biologika Gmbh — Dessau-Rosslau, Germany (Active)
Researchers
- Principal investigator: Cristina, Arbelo — Idt Biologika Gmbh
- Study coordinator: Cristina, Arbelo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.